Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of September 25, 2026, UTMD trades at $74.37 with a market cap of $238.82M and a P/E ratio of 22.71. UTMD moved +0.00% today. Year to date, UTMD is +32.30%; over the trailing twelve months it is +18.90%. Its 52-week range spans $51.26 to $76.89. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Utah Medical corrects tender offer expiration date to Oct. 7 Wednesday: Utah Medical Products corrected its tender offer communications, confirming the offer expires at 5:00 p.m. New York time on Wednesday, Oct. 7. The offer seeks up to 650,000 common shares at $75 per share, unless extended.
| Metric | Value |
|---|---|
| Price | $74.37 |
| Market Cap | $238.82M |
| P/E Ratio | 22.71 |
| EPS | $3.28 |
| Dividend Yield | 0.31% |
| 52-Week High | $76.89 |
| 52-Week Low | $51.26 |
| Volume | 5.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $36.11M |
| Net Income | $10.49M |
| Gross Margin | 57.90% |
UTMD analyst coverage data. Average price target: $0.00.